Le Lézard
Classified in: Science and technology
Subject: CALENDAR OF EVENTS

Topicus.com Inc. Announces Release Date for Fourth Quarter Results


TORONTO, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its fourth quarter results on February 8, 2022.

The Company's quarterly results will be disseminated via press release and made available on the Company's website (www.topicus.com) and SEDAR, after markets close on Tuesday, February 8, 2022.  

About Topicus.com Inc.

Topicus' subordinate voting shares are listed on the Toronto Venture Stock Exchange under the symbol "TOI". Topicus acquires, manages and builds vertical market software businesses.

Contact:

Jamal Baksh
Chief Financial Officer
416-861-9677



These press releases may also interest you

at 16:55
Paystand Acquires Teampay for Giant Leap Toward B2B Payment Revolution
Paystand, the global leader in blockchain-enabled B2B payments, today announced the acquisition of Teampay, an industry-leading spend management software. The transaction creates a B2B payments powerhouse whose continued goal is to revolutionize...

at 16:52
MAGNA5 RECEIVES TRIPLE RECOGNITION IN THE 2024 TOP WORKPLACES AWARDS FOR OUTSTANDING CULTURE, INNOVATION, AND LEADERSHIP
Magna5, a leading national provider of managed IT, cybersecurity, and cloud-based services, is proud to announce its achievement of three 2024 Top Workplaces awards. These honors are a testament to the company's commitment to fostering an innovative,...

at 16:50
New Research from Material and NewtonX Reveals Shifts in Digital Ad Spending and Social Media Strategies
A new research report conducted by Material and NewtonX reveals data and insights into the future of advertising, spotlighting trends in targeting, technology, social media and the impact of AI on marketing. The report, The Digital Lead: 2024...

at 16:50
FinVolution Group Files 2023 Annual Report on Form 20-F
FinVolution Group ("FinVolution," or the "Company") , a leading fintech platform, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the Securities and Exchange Commission (the "SEC") on...

at 16:45
Mahesh Krishnan Elected to Halozyme's Board of Directors
Halozyme Therapeutics, Inc. ("Halozyme") today announced the election of Mahesh Krishnan, M.D. to its Board of Directors. Dr. Krishnan has more than 20 years of experience in healthcare, biotechnology and health services. "Mahesh is a dynamic and...

at 16:45
Recon Technology Announces 1-for-18 Reverse Stock Split
Recon Technology, Ltd. ("Recon" or the "Company") announced today that the Company's shareholders approved on March 29, 2024 to effect a reverse stock split of the Company's Class A ordinary shares at the ratio of one-for-eighteen with the market...

More news about Science and technology...


News published on and distributed by: